Providence Capital Advisors, LLC Abbott Laboratories Transaction History

Providence Capital Advisors, LLC

$445 Million
Q1 2024

A detailed history of Providence Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 61,372 shares of ABT stock, worth $6.38 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares

61,372

Previous 112,852 45.62%

Holding current value

$6.38 Million

Previous $10.9 Million 36.18%

% of portfolio

1.57%

Previous 2.96%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $5.64 Million - $6.23 Million	-51,480 Reduced 45.62%	61,372 $6.98 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $6.27 Million - $7.52 Million	65,591 Added 138.78%	112,852 $10.9 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $18,140 - $20,212	180 Added 0.38%	47,261 $5.15 Million
Q1 2023 May 17, 2023	SELL	$96.86 - $114.01 $457 Million - $538 Million	-4,720,377 Reduced 99.01%	47,081 $4.77 Million
Q1 2023 May 17, 2023	BUY	$96.86 - $114.01 $462 Million - $544 Million	4,767,454 Added 0.0%	4,767,458 $483 Million

Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $4.66 Million - $5.49 Million	-48,136 Reduced 99.99%	4 $0
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $18,251 - $21,411	192 Added 0.4%	48,140 $5.29 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $457,287 - $529,453	4,726 Added 10.93%	47,948 $4.64 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $126,056 - $152,361	-1,235 Reduced 2.78%	43,222 $4.7 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $139,332 - $169,906	1,222 Added 2.83%	44,457 $5.26 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $5,545 - $6,790	48 Added 0.11%	43,235 $6.09 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $201,938 - $223,402	1,731 Added 4.18%	43,187 $5.1 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $87,065 - $102,488	823 Added 2.03%	41,456 $4.81 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $134,635 - $158,620	1,237 Added 3.14%	40,633 $4.87 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $1.19 Million - $1.3 Million	11,337 Added 40.4%	39,396 $4.31 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $38,580 - $46,853	-421 Reduced 1.48%	28,059 $3.05 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $12,174 - $15,582	-159 Reduced 0.56%	28,480 $2.6 Million
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $169,739 - $248,205	2,702 Added 10.42%	28,639 $2.26 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $30,069 - $33,474	383 Added 1.5%	25,937 $2.25 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $71,282 - $77,292	871 Added 3.53%	25,554 $2.14 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $31,994 - $37,315	439 Added 1.81%	24,683 $2.08 Million
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $44,830 - $54,200	677 Added 2.87%	24,244 $1.94 Million
Q4 2018 Feb 01, 2019	BUY	$65.56 - $74.27 $1.55 Million - $1.75 Million	23,567 New	23,567 $1.71 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $1,688 - $1,908	-30 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $1,610 - $1,724	30	30 $2,000

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Abbott Laboratories Transaction History